Global Dermal Fillers and Botulinum Toxin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 148315
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Botulinum toxin (BTX) or Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

Scope of the Report:

This report focuses on the Dermal Fillers and Botulinum Toxin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.

The worldwide market for Dermal Fillers and Botulinum Toxin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Allergan

Galderma

Merz

Anika

Suneva

Speciality

HUGEL

Grex

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hyaluronic Acid Based Fillers

Non-Hyaluronic Acid Based Fillers

Botulinum Toxin

Market Segment by Applications, can be divided into

Aesthetic Volume Restoration

Wrinkle Reduction

There are 15 Chapters to deeply display the global Dermal Fillers and Botulinum Toxin market.

Chapter 1, to describe Dermal Fillers and Botulinum Toxin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dermal Fillers and Botulinum Toxin, with sales, revenue, and price of Dermal Fillers and Botulinum Toxin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermal Fillers and Botulinum Toxin, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dermal Fillers and Botulinum Toxin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dermal Fillers and Botulinum Toxin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Dermal Fillers and Botulinum Toxin Introduction

1.2 Market Analysis by Type

1.2.1 Hyaluronic Acid Based Fillers

1.2.2 Non-Hyaluronic Acid Based Fillers

1.2.3 Botulinum Toxin

1.3 Market Analysis by Applications

1.3.1 Aesthetic Volume Restoration

1.3.2 Wrinkle Reduction

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Galderma

2.2.1 Business Overview

2.2.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merz

2.3.1 Business Overview

2.3.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merz Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Anika

2.4.1 Business Overview

2.4.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Anika Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Suneva

2.5.1 Business Overview

2.5.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Suneva Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Speciality

2.6.1 Business Overview

2.6.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Speciality Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 HUGEL

2.7.1 Business Overview

2.7.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 HUGEL Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Grex

2.8.1 Business Overview

2.8.2 Dermal Fillers and Botulinum Toxin Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Grex Dermal Fillers and Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Dermal Fillers and Botulinum Toxin Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Dermal Fillers and Botulinum Toxin Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Dermal Fillers and Botulinum Toxin Manufacturer Market Share in 2017

3.3.2 Top 6 Dermal Fillers and Botulinum Toxin Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Dermal Fillers and Botulinum Toxin Market Analysis by Regions

4.1 Global Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Regions

4.1.1 Global Dermal Fillers and Botulinum Toxin Sales and Market Share by Regions (2013-2018)

4.1.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Regions (2013-2018)

4.2 North America Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

4.3 Europe Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

4.5 South America Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

5 North America Dermal Fillers and Botulinum Toxin by Countries

5.1 North America Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Countries

5.1.1 North America Dermal Fillers and Botulinum Toxin Sales and Market Share by Countries (2013-2018)

5.1.2 North America Dermal Fillers and Botulinum Toxin Revenue and Market Share by Countries (2013-2018)

5.2 United States Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

5.3 Canada Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

5.4 Mexico Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

6 Europe Dermal Fillers and Botulinum Toxin by Countries

6.1 Europe Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Countries

6.1.1 Europe Dermal Fillers and Botulinum Toxin Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue and Market Share by Countries (2013-2018)

6.2 Germany Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

6.3 UK Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

6.4 France Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

6.5 Russia Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

6.6 Italy Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

7 Asia-Pacific Dermal Fillers and Botulinum Toxin by Countries

7.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Market Share by Countries (2013-2018)

7.2 China Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

7.3 Japan Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

7.4 Korea Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

7.5 India Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

8 South America Dermal Fillers and Botulinum Toxin by Countries

8.1 South America Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Countries

8.1.1 South America Dermal Fillers and Botulinum Toxin Sales and Market Share by Countries (2013-2018)

8.1.2 South America Dermal Fillers and Botulinum Toxin Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

8.3 Argentina Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

8.4 Colombia Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

9 Middle East and Africa Dermal Fillers and Botulinum Toxin by Countries

9.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

9.3 UAE Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

9.4 Egypt Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

9.5 Nigeria Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

9.6 South Africa Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2013-2018)

10 Global Dermal Fillers and Botulinum Toxin Market Segment by Type

10.1 Global Dermal Fillers and Botulinum Toxin Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Dermal Fillers and Botulinum Toxin Sales and Market Share by Type (2013-2018)

10.1.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2013-2018)

10.2 Hyaluronic Acid Based Fillers Sales Growth and Price

10.2.1 Global Hyaluronic Acid Based Fillers Sales Growth (2013-2018)

10.2.2 Global Hyaluronic Acid Based Fillers Price (2013-2018)

10.3 Non-Hyaluronic Acid Based Fillers Sales Growth and Price

10.3.1 Global Non-Hyaluronic Acid Based Fillers Sales Growth (2013-2018)

10.3.2 Global Non-Hyaluronic Acid Based Fillers Price (2013-2018)

10.4 Botulinum Toxin Sales Growth and Price

10.4.1 Global Botulinum Toxin Sales Growth (2013-2018)

10.4.2 Global Botulinum Toxin Price (2013-2018)

11 Global Dermal Fillers and Botulinum Toxin Market Segment by Application

11.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2013-2018)

11.2 Aesthetic Volume Restoration Sales Growth (2013-2018)

11.3 Wrinkle Reduction Sales Growth (2013-2018)

12 Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.1 Global Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate (2018-2023)

12.2 Dermal Fillers and Botulinum Toxin Market Forecast by Regions (2018-2023)

12.2.1 North America Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.2.2 Europe Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.2.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.2.4 South America Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.2.5 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Forecast (2018-2023)

12.3 Dermal Fillers and Botulinum Toxin Market Forecast by Type (2018-2023)

12.3.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2018-2023)

12.3.2 Global Dermal Fillers and Botulinum Toxin Market Share Forecast by Type (2018-2023)

12.4 Dermal Fillers and Botulinum Toxin Market Forecast by Application (2018-2023)

12.4.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2018-2023)

12.4.2 Global Dermal Fillers and Botulinum Toxin Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Dermal Fillers and Botulinum Toxin Picture

Table Product Specifications of Dermal Fillers and Botulinum Toxin

Figure Global Sales Market Share of Dermal Fillers and

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery